[1] Pushpakumar S, Kundu S, Sen U. Endothelial dysfunction: the link between homocysteine and hydrogen sulfide[J]. Curr Med Chem, 2014, 21(32): 3662-3672. [2] Kaplan J R, Manuck S B. Using ethological principles to study psychosocial influences on coronary atherosclerosis in monkeys[J]. Acta PhysiolScand Suppl, 1997, 640: 96-99. [3] Ketterer M W, Mahr G, Goldberg A D. Psychological factors affecting a medical condition: ischemic coronary heart disease[J]. J Psychosom Res, 2000, 48(4-5): 357-367. [4] Vitaliano P P, Scanlan J M, Zhang J, et al. A path model of chronic stress, the metabolic syndrome, and coronary heart disease[J]. Psychosom Med, 2002, 64(3): 418-435. [5] Zhao L P, You T, Chan S P, et al. Adropin is associated with hyperhomocysteine and coronary atherosclerosis[J]. Exp Ther Med, 2016, 11(3): 1065-1070. [6] Gensini G G.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol, 1983, 51(3) :606. [7] 胡司淦, 徐玮, 谢彩侠, 等.双心医学治疗模式在冠状动脉介入术后伴发抑郁焦虑患者中的应用[S].华北理工大学学报 (医学版) , 2018:239. [8] 汪斌, 孙震, 沐露霞, 等.“双心医学”对冠心病临界病变伴焦虑和抑郁患者的影响[J].安徽医学, 2018, 39(2) :205. [9] Smith SC. Current and future directions of cardiovascular risk prediction. Am J Cardiol[J]. 2006,97(28):32. [10] Akhabue E, Thiboutot J, Cheng J W, et al. New and emerging risk factors for coronary heart disease[J]. Am J Med Sci, 2014, 347(2): 151-158. [11] Gariglio L, Riviere S, Morales A, et al. Comparison of homocysteinemia and MTHFR 677CT polymorphism with Framingham Coronary Heart Risk Score[J]. Arch Cardiol Mex, 2014, 84(2): 71-78. [12] Ma Y, Peng D, Liu C, et al. Serum high concentrations of homocysteine and low levels of folic acid and vitamin B12 are significantly correlated with the categories of coronary artery diseases[J]. BMC Cardiovasc Disord, 2017, 17(1): 37. [13] Wu Y, Huang Y, Hu Y, et al. Hyperhomocysteinemia is an independent risk factor in young patients with coronay artery disease in southern China[J]. Herz. 2013,38(7):779-784. [14] Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA[J]. 2002,288(16):2015-2022. [15] Joubran R, Asmi M, Busjahn A, et al. Homocysteine levels and coronary heart disease in Syri[J]. J Cardiovasc Risk, 1998,5:257-261. [16] Karadeniz M, Sarak T, Duran M, et al. Hyperhomocysteinemia predicts the severity of coronary artery disease as determined by the SYNTAX score in patients with acute coronary syndrome[J]. Acta Cardiol Sin, 2017,33:664-669. [17] Khayyam-Nekouei Z,Neshatdoost H,Yousefy A,et al.Psychological factors and coronary heart disease[J]. ARYA Atheroscler,2013,9(1):102-111. [18] Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med[J]. 2004,66(3):305-315. [19] Ren Y,Yang H,Browning C,Thomas S,et alPrevalence of depression in coronary heart disease in China: a systematic review and meta-analysis[J]. Chin Med J (Engl),2014,127(16):2991-2998. [20] Khayyam-Nekouei Z,Neshatdoost H,Yousefy A,et al.Psychological factors and coronary heart disease[J]. ARYA Atheroscler,2013,9(1):102-111. |